Medicines appraisal cards

Medicines appraisal cards have been developed for the Guidelines in Practice audience to announce new recommendations from the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), and the All Wales Medicines Strategy Group (AWMSG). Items may contain pharmaceutical promotional information.

Cosentyx (secukinumab) TA card

NICE Technology Appraisal 719: Secukinumab for treating non-radiographic axial spondyloarthritis

Commissioned by Novartis Pharmaceuticals UK Ltd

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. 
View Cosentyx (secukinumab) prescribing and adverse event reporting information
MLR ID 147195  August 2021

Evenity index image

Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280

Commissioned by UCB Pharma Ltd

The production of this Guidelines card has been commissioned by UCB Pharma Ltd. 
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020